ADAPTIMMUNE THERAPEUTICS PLC Restructuring and Related Cost, Cost Incurred to Date
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Restructuring and Related Cost, Cost Incurred to Date of $5.91 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Restructuring and Related Activities › Restructuring and Related Cost, Expected Cost
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2025-08-13
- 2025-06-30: Restructuring and Related Cost, Cost Incurred to Date $5.91M.
- 2025-03-31: Restructuring and Related Cost, Cost Incurred to Date $5.91M.
- 2024-12-31: Restructuring and Related Cost, Cost Incurred to Date $5.91M.
- 2023-12-31: Restructuring and Related Cost, Cost Incurred to Date $1.70M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2025-06-30 | $5.91M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $5.91M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.91M 10-K · filed 2025-03-24 |
| 2023-12-31 | $1.70M 10-K · filed 2025-03-24 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.29M 10-K · filed 2025-03-24 |